Skip to contentP
Prestige Consumer Healthcare Inc.
P
PBHPrestige Consumer Healthcare Inc. Q4 2018 · 10-K
Revenue$255.97M$255.97M+6.4% vs Q4 2017 Net Income-$39.69M-$39.69MN/M vs Q4 2017 EPS Diluted-$0.75-$0.75N/M vs Q4 2017 Gross Profit$141,257,000+8.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Prestige Consumer Healthcare Inc. · CIK 1295947 · Engraved from SEC EDGAR
Operating Cash Flowderived$54,438,000+633.3% Free Cash Flowderived$51,562,000+707.9% Margins · derivedGross margin55.2%+1.1 pt vs Q4 2017
Operating margin-9.0%−31.1 pt vs Q4 2017
Net margin-15.5%−20.1 pt vs Q4 2017
ended Mar 31, 2018 · filed May 10, 2018 · 40 d after period end